Risk of Symptomatic Skeletal Events After Discontinuation of Long-term Denosumab in Patients With Bone Metastases: A Retrospective Cohort Study

Clinical Oncology 2026 Open access

Read full text

Authors: Hitomi Hara, Naomasa Fukase, Ryoko Sawada, Toshiyuki Takemori, Yuta Nakamatsu, Ryosuke Kuroda, Toshihiro Akisue

DOI: 10.1016/j.clon.2026.104058

Cited by: 2

References: 13

Fields of Study & Subjects

Bone health and treatments Management of metastatic bone disease Parathyroid Disorders and Treatments

References 13